Physician
Rheumatology
Dr. Walford J. Fessel, MD
|
|
Give Review
Walford Fessel practices Rheumatology. Walford J. Fessel, MD is a published MD. He published 101 publications, including: 'Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicen...'
Publications
- [A contribution to Mirizzi syndrome].
- Megestrol acetate and hyperpnea.
- Epidemiology of systemic lupus erythematosus.
- Globulins and behavior in schizophrenia.
- Polymyalgia rheumatica, temporal arteritis, and contact with birds.
- Myalgia and bird-keeping.
- Fat disorders and peripheral neuropathy.
- Rheumatic manifestations of hypophosphatemia.
- Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women.
- Muscle diseases in rheumatology.
- Angiographic demonstration of major cerebral vessel occlusion in systemic lupus erythematosus.
- Remote effects of benign neoplasms.
- Correlates and consequences of asymptomatic hyperuricemia.
- Autoimmunity in the pathogenesis of muscle disease.
- Assessing quality of care from the medical record.
- Immunologic reactivity in hyperuricemia.
- Medical record as index of quality of care.
- Hyperuricemia in health and disease.
- Pathogenesis of diabetic and alcoholic neuropathy.
- Atheromatous microembolism simulating polymyositis.
- Myopathy of hypothyroidism.
- Genetic and stress factors affecting the abnormal lymphocyte in schizophrenia.
- Polymyalgia rheumatica and blindness.
- The nature of illness and diagnosis.
- Strategic aspects of prescription writing.
- Idiopathic hypertrophic osteoarthropathy (pachydermoperiostosis).
- High uric acid as an indicator of cardiovascular disease. Independence from obesity.
- Megadose corticosteroid therapy in systemic lupus erythematosus.
- Early treatment of HIV infection.
- Multicenter trial of octreotide in patients with refractory acquired immunodeficiency syndrome-associated diarrhea.
- Cryptococcal meningitis after unusual exposures to birds.
- Viral load and response to treatment of HIV.
- Human immunodeficiency virus (HIV) RNA in plasma as the preferred target for therapy in patients with HIV infection: a critique.
- Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
- Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicen...
- A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseas...
- Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
- Dissociation of immunologic and virologic responses to highly active antiretroviral therapy.
- Salvage therapy and formulation of highly active antiretroviral therapy.
- Thalidomide for the treatment of AIDS-associated wasting.
- Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-contr...
- Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068.
- Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapy.
- High-density lipoprotein cholesterol is low in HIV-infected patients with lipodystrophic fat expansions: implications for pathogenesis of fat redistribution.
- Is HIV sequestered in bone? Possible implications of virological and immunological findings in some HIV-infected patients with bone disease.
- Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors.
- Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.
- Intra-cutaneous Congo red in rheumatoid arthritis.
- Electrophoretic and analytical ultra-centrifuge studies in sera of psychotic patients: elevation of gamma globulins and macroglobulins, and splitting of alpha globulins.
- Disturbed serum proteins in chronic psychosis. Serological, medical and psychiatric correlations.
- Serum protein abnormalities in psychosis: a preliminary report.
- Psychosis and systemic lupus erythematosus: a review of the literature and case reports.
- Nucleoprotein-latex agglutination test in connective tissue diseases.
- Autoimmunity and mental illness. A preliminary report.
- Blood proteins in functional psychoses. A review of the literature and unifying hypothesis.
- Macroglobin elevations in functional mental illness.
- Serum protein disturbance in retinitis pigmentosa and the association of retinitis pigmentosa with psychosis.
- Distinctive protein patterns in functional psychoses.
- Loss of immunological reactivity of an alpha-2 globulin after prolonged freezing of serum.
- Clinical analysis of 142 cases with high molecular weight serum proteins.
- The "antibrain" factors in psychiatric patients'' sera. I. Further studies with a hemagglutination technique.
- Multiple antigenic determinants on macroglobulins.
- ABNORMAL LEUKOCYTES IN SCHIZOPHRENIA.
- CLINICAL ASPECTS OF A SEROLOGIC STUDY OF PSYCHOSES.
- THE BONE MARROW IN SCHIZOPHRENIA.
- SEROLOGICAL DISTINCTION BETWEEN FUNCTIONAL PSYCHOSES.
- INTERACTION OF MULTIPLE DETERMINANTS OF SCHIZOPHRENIA; A TENTATIVE SYNTHESIS AND REVIEW.
- WHAT IS THE ALBUMIN LEVEL?A COMPARISON OF METHODS FOR ALBUMIN DETERMINATION.
- PERIPHERAL VASOCONSTRICTION INDUCED BY EMOTIONAL STRESS IN RATS.
- ODD MEN OUT: INDIVIDUALS WITH EXTREME VALUES.
- Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.
- HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance.
- Comparison of atazanavir with lopinavir/ritonavir in patients with prior protease inhibitor failure: a randomized multinational trial.
- HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.
- N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
- Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriat...
- Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance.
- Virologic efficacy of boosted double versus boosted single protease inhibitor therapy.
- Prevalence of darunavir resistance-associated mutations: patterns of occurrence and association with past treatment.
- Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.
- Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection.
- Human immunodeficiency virus type 1 isolates with the reverse transcriptase (RT) mutation Q145M retain nucleoside and nonnucleoside RT inhibitor susceptibility.
- Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database.
- Advantages of predicted phenotypes and statistical learning models in inferring virological response to antiretroviral therapy from HIV genotype.
- Predictive value of HIV-1 genotypic resistance test interpretation algorithms.
- Impaired neurocognition in HIV-infected patients: antecedents and treatment.
- Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.
- Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generatio...
- Panel of prototypical raltegravir-resistant infectious molecular clones in a novel integrase-deleted cloning vector.
- Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.
- HIV-1 protease mutations and protease inhibitor cross-resistance.
- HIV-1 integrase sequence variability in antiretroviral naïve patients and in triple-class experienced patients subsequently treated with raltegravir.
- Association of osteonecrosis and osteoporosis in HIV-1-infected patients.
- The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment.
- Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factor.
- Letter: HL-A 27 (W27) absent in gonococcal arthritis.
- Mixed connective-tissue disease.
- ANA-negative systemic lupus erythematosus.
- Systemic lupus erythematosus as seen in primary care.
- Renal outcomes of gout and hyperuricemia.
Schools
University Of London Faculty Of Medicine Charing Cross Hospital
University College Hospital
Canadian Red Cross Hospital
University Calif San Francisco
Doctors Specialties
- Internal Medicine
- Rheumatology
Accepted Insurances
Education
-
UCSF
Helpful Reviews
Similar Doctors
|
Dr. Kenneth B. Tai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael G. Shlipak, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Emerald M. Spencer, MD |
|
|
Dr. James A. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia A. Yeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon A. Chung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie E. Zikherman, MD
This Doctor is OpenDoctor Recommended.
|